Drug Approval | March 04, 2023
Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
he product will be launched shortly in the US market.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
This combination medicine is used to treat high blood pressure (hypertension).
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Subscribe To Our Newsletter & Stay Updated
